Importer of Controlled Substances; Notice of Registration; Formulation Technologies, LLC, 30025 [2012-12241]

Download as PDF 30025 Federal Register / Vol. 77, No. 98 / Monday, May 21, 2012 / Notices Dated: May 16, 2012. Benjamin J. Robinson, Deputy Rules Officer and Counsel. Washington, DC 20544, telephone (202) 502–1820. Dated: May 16, 2012. Benjamin J. Robinson, Deputy Rules Officer and Counsel. [FR Doc. 2012–12255 Filed 5–16–12; 4:15 pm] BILLING CODE 2210–55–P [FR Doc. 2012–12266 Filed 5–16–12; 4:15 pm] JUDICIAL CONFERENCE OF THE UNITED STATES BILLING CODE 2210–55–P Meeting of the Judicial Conference Advisory Committee on Rules of Bankruptcy Procedure DEPARTMENT OF JUSTICE Judicial Conference of the United States. ACTION: Notice of open meeting. Importer of Controlled Substances; Notice of Application; Stepan Company Drug Enforcement Administration AGENCY: The Advisory Committee on Rules of Bankruptcy Procedure will hold a two-day meeting. The meeting will be open to public observation but not participation. DATES: September 20–21, 2012. Time: 8:30 a.m. to 5 p.m. ADDRESSES: Hotel Monaco Portland, 506 SW Washington Street, Portland, OR 97204. SUMMARY: FOR FURTHER INFORMATION CONTACT: Benjamin J. Robinson, Deputy Rules Officer and Counsel, Administrative Office of the United States Courts, Washington, DC 20544, telephone (202) 502–1820. Dated: May 16, 2012. Benjamin J. Robinson, Deputy Rules Officer and Counsel. [FR Doc. 2012–12258 Filed 5–16–12; 4:15 pm] BILLING CODE 2210–55–P JUDICIAL CONFERENCE OF THE UNITED STATES Meeting of the Judicial Conference Committee on Rules of Practice and Procedure Judicial Conference of the United States. ACTION: Notice of open meeting. AGENCY: The Committee on Rules of Practice and Procedure will hold a twoday meeting. The meeting will be open to public observation but not participation. SUMMARY: June 11–12, 2012. Time: 8:30 a.m. to 5 p.m. ADDRESSES: Thurgood Marshall Federal Judiciary Building, Mecham Conference Center, One Columbus Circle NE., Washington, DC 20544. FOR FURTHER INFORMATION CONTACT: Benjamin J. Robinson, Deputy Rules Officer and Counsel, Administrative Office of the United States Courts, ebenthall on DSK5SPTVN1PROD with NOTICES DATES: VerDate Mar<15>2010 18:18 May 18, 2012 Jkt 226001 This is notice that on February 27, 2012, Stepan Company, Natural Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of Coca Leaves (9040), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance to manufacture bulk controlled substance for distribution to its customer. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745, all applicants for registration to import a basic class of any controlled substance in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: May 11, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–12248 Filed 5–18–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Formulation Technologies, LLC By Notice dated January 26, 2012, and published in the Federal Register on February 6, 2012, 77 FR 5845, PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 Formulation Technologies, LLC., 11501 Domain Drive, Suite 130, Austin, Texas 78758, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Fentanyl (9801), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance for analytical research and clinical trials. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Formulation Technologies, LLC. to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Formulation Technologies, LLC. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: May 11, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–12241 Filed 5–18–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Agilent Technologies Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 11, 2012, Agilent Technologies, 25200 Commercentre Drive, Lake Forest, California 92630–8810, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: Drug Phencyclidine (7471) .................... E:\FR\FM\21MYN1.SGM 21MYN1 Schedule II

Agencies

[Federal Register Volume 77, Number 98 (Monday, May 21, 2012)]
[Notices]
[Page 30025]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12241]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Formulation Technologies, LLC

    By Notice dated January 26, 2012, and published in the Federal 
Register on February 6, 2012, 77 FR 5845, Formulation Technologies, 
LLC., 11501 Domain Drive, Suite 130, Austin, Texas 78758, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of Fentanyl (9801), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
analytical research and clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Formulation Technologies, LLC. to import the basic 
class of controlled substance is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. DEA has 
investigated Formulation Technologies, LLC. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substance 
listed.

    Dated: May 11, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-12241 Filed 5-18-12; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.